Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.,
, Front. Cell. Infect. Microbiol., Volume 4, p.24/1–24/7, (2014)
Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.,
, J. Antimicrob. Chemother., Volume 70, Number 6, p.1727–1737, (2015)